Publication | Closed Access

Sacubitril/valsartan reduces susceptibility to atrial fibrillation by improving atrial remodeling in spontaneously hypertensive rats

HypertensionCardiovascular DiseaseMedicineAntihypertensive TherapyPhysiologyCardiovascular PharmacologyVascular BiologyPharmacotherapyAtrial RemodelingAtrial FibrillationPublic HealthPharmacologyHypertensive RatsCardiologyDiastolic Function